Efficacy of biologics and oral small molecules for atopic dermatitis: a systematic review and meta-analysis.

Kelsey B NusbaumSarah FleischerAlan B Fleischer

Published in: The Journal of dermatological treatment (2021)

Upadacitinib, abrocitinib, and lebrikizumab had greater improvement of clinical signs, symptoms, and quality of life in AD compared to dupilumab and other targeted therapies.

Keyphrases

atopic dermatitis
sleep quality
depressive symptoms